Mardinger Ofer, Nissan Joseph, Chaushu Gavriel
Department of Oral and Maxillofacial Surgery, Sapir Medical Center, Kefar Saba, Israel.
J Periodontol. 2007 Oct;78(10):1872-7. doi: 10.1902/jop.2007.070175.
A one-stage surgical technique has been adopted that allows simultaneous implant placement in as little as 1 to 2 mm of residual bone. The aim of this retrospective study was to describe results and complications in sinus augmentation of severely atrophic edentulous maxillae in patients with 1 to 3 mm residual bone height and compare them to a group of patients treated following the standard protocol with residual bone height > 4 mm.
The study consisted of a study group (N = 25) and a control group (N = 30). All patients were consecutive admissions treated for one-stage sinus augmentation by one surgeon during the years 2001 to 2005. Patients' medical files were reviewed mainly regarding operative technical problems and complications.
Included in the study were 60 sinuses and 164 simultaneous implants placed in grafted maxillary sinuses. Eight implants failed, seven of which were in the study group; three were in heavy smokers with residual bone of 1 to 3 mm. The success rate was 92% for the study group and 98.7% for the control group. A borderline statistically significant difference was found in the success rates between the groups using the Fisher exact test (P = 0.069).
Sinus augmentation with simultaneous implant placement can be used to treat the atrophic maxilla in patients with 1 to 3 mm of vertical residual bone height when careful case planning and surgical techniques are used.
已采用一种一期手术技术,该技术允许在仅1至2毫米的剩余骨中同时植入种植体。本回顾性研究的目的是描述在剩余骨高度为1至3毫米的严重萎缩无牙上颌窦提升术中的结果和并发症,并将其与一组按照标准方案治疗且剩余骨高度>4毫米的患者进行比较。
该研究包括一个研究组(N = 25)和一个对照组(N = 30)。所有患者均为2001年至2005年期间由一名外科医生连续收治并接受一期上颌窦提升术的患者。主要查阅患者的病历,了解手术技术问题和并发症情况。
本研究共纳入60个上颌窦和164颗同时植入移植上颌窦的种植体。8颗种植体失败,其中7颗在研究组;3颗在剩余骨为1至3毫米的重度吸烟者中。研究组的成功率为92%,对照组为98.7%。使用Fisher精确检验发现两组成功率之间存在边缘统计学显著差异(P = 0.069)。
当采用仔细的病例规划和手术技术时,上颌窦提升术同时植入种植体可用于治疗垂直剩余骨高度为1至3毫米的萎缩性上颌骨。